肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2013年
6期
375-377,381
,共4页
食管肿瘤%外科手术%预后因素
食管腫瘤%外科手術%預後因素
식관종류%외과수술%예후인소
Esophageal neoplasms%Surgical operation%Prognostic factors
目的 分析病理T2~3N0食管癌临床病理特征对预后的影响.方法 回顾性分析422例病理T2~3N0胸段食管癌患者的临床资料,应用Kaplan-Meier法进行单因素生存分析,组间比较用Log-rank 检验,多因素生存分析采用Cox模型分析.结果 总的1、3和5年生存率分别为89.3%、63.5%、52.5%.单因素生存分析结果显示性别、肿瘤浸润深度和组织分化是影响食管癌预后的因素(x2值分别为7.45、7.79、15.81,均P<0.01),Cox回归多因素生存分析显示性别、肿瘤浸润深度和组织分化也是食管癌预后的独立影响因素.结论 性别、肿瘤浸润深度和组织分化是病理T2~3N0食管癌预后的独立影响因素,外科手术是病理T2~3N0食管癌的标准治疗方法.
目的 分析病理T2~3N0食管癌臨床病理特徵對預後的影響.方法 迴顧性分析422例病理T2~3N0胸段食管癌患者的臨床資料,應用Kaplan-Meier法進行單因素生存分析,組間比較用Log-rank 檢驗,多因素生存分析採用Cox模型分析.結果 總的1、3和5年生存率分彆為89.3%、63.5%、52.5%.單因素生存分析結果顯示性彆、腫瘤浸潤深度和組織分化是影響食管癌預後的因素(x2值分彆為7.45、7.79、15.81,均P<0.01),Cox迴歸多因素生存分析顯示性彆、腫瘤浸潤深度和組織分化也是食管癌預後的獨立影響因素.結論 性彆、腫瘤浸潤深度和組織分化是病理T2~3N0食管癌預後的獨立影響因素,外科手術是病理T2~3N0食管癌的標準治療方法.
목적 분석병리T2~3N0식관암림상병리특정대예후적영향.방법 회고성분석422례병리T2~3N0흉단식관암환자적림상자료,응용Kaplan-Meier법진행단인소생존분석,조간비교용Log-rank 검험,다인소생존분석채용Cox모형분석.결과 총적1、3화5년생존솔분별위89.3%、63.5%、52.5%.단인소생존분석결과현시성별、종류침윤심도화조직분화시영향식관암예후적인소(x2치분별위7.45、7.79、15.81,균P<0.01),Cox회귀다인소생존분석현시성별、종류침윤심도화조직분화야시식관암예후적독립영향인소.결론 성별、종류침윤심도화조직분화시병리T2~3N0식관암예후적독립영향인소,외과수술시병리T2~3N0식관암적표준치료방법.
Objective To analyze the clinicopathologic features of patients with pathologic T2-3N0 thoracic esophageal squamous cell carcinoma (ESCC) and correlation to their prognosis.Methods The clinicopathologic data of 422 patients with pathologic T2-3N0 thoracic ESCC,who were treated with surgery were analyzed.Cumulative survival rate was analyzed by the Kaplan-Meier method and compared by Log-rank test.Cox regression model was used for multivariate prognostic analysis.Results The overall 1-,3-and 5-year survival rates were 89.3 %,63.5 % and 52.5 %,respectively.Univariate analysis revealed that the factors affecting the prognosis included gender (x2 =7.45,P < 0.01),depth of invasion (x2 =7.79,P < 0.01) andtissues differentiation (x2 =15.81,P < 0.01).They were also independent prognostic factors according Cox regression multivariate survival analysis.Conclusion The gender,depth of invasion and differentiation should be independent prognostic factors of pathologic T2-3N0 ESCC.Surgery is still the standard treatment for pathologic T2-3N0 esophageal cancer.